0:00:06 | i this is that remote "'cause" you providing an overview on a paper that salute |
---|
0:00:10 | integrated real valued thing stand safety and efficacy for the treatment of coronary artery disease |
---|
0:00:16 | the need to develop a local and tied eastern optic mechanism to prevent in standard |
---|
0:00:21 | least analyses and from both sees as driven the development of new generation stands |
---|
0:00:26 | the resolute introduced into cells that are a little muscle you think system with the |
---|
0:00:31 | new by links polymers that allows all |
---|
0:00:34 | so the word revolution |
---|
0:00:36 | recently available data has shown that clinical efficacy and safety of distend in randomized an |
---|
0:00:42 | observational studies |
---|
0:00:44 | there is a list and system has demonstrated non inferiority when compared with other stands |
---|
0:00:49 | and holes the problem is to treat more complex corner deletions |
---|
0:00:54 | the resolute integrate extent uses one continuous sinusoidal metallic strand the enhanced range of motion |
---|
0:01:01 | which may result in easier and safer delivery |
---|
0:01:04 | and add to the technical advantage for the intervention a list |
---|
0:01:08 | by reducing the profile an improved pushable at |
---|
0:01:12 | the data on clinical efficacy is promising and the safety so far is acceptable |
---|
0:01:17 | to the c in level as other widely used drug eluding stands |
---|
0:01:21 | longer term fall open for their bolster efficacy and safety issues |
---|
0:01:26 | as the use of the device extends across the us in the world we need |
---|
0:01:30 | to continue to monitor the real world leaves and results to determine whether the efficacy |
---|
0:01:35 | and safety results will remain generalize able to follow beyond two years and in specific |
---|
0:01:42 | higher this subgroup |
---|
0:01:44 | there is no doubt that disdainful have a major role in the treatment of coronary |
---|
0:01:48 | artery disease in the near future |
---|
0:01:51 | off node their absolute integrity standards a forced ts approved by they have da for |
---|
0:01:55 | use in patients with diabetes |
---|
0:01:58 | we have gone for about thirty percent of thing nearly one million connally interventions perform |
---|
0:02:03 | in the u s e g |
---|
0:02:05 | overall the resolute integrate deep |
---|
0:02:08 | stands this ten |
---|
0:02:10 | as several notable benefits including outstanding delivery ability |
---|
0:02:15 | which means is easy to deliver to those channels inside |
---|
0:02:19 | efficacy in complex patients and diacritics but additional longer tone data |
---|
0:02:24 | safety and efficacy i need a to semantic space in the dsr moment at a |
---|
0:02:29 | thank you |
---|